Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-01

FDA Approved: ARTHRITIS PAIN RELIEVER — Supplemental Application (Publix Super Markets Inc)

View source ↗

Summary

FDA approved a supplemental application for Publix Super Markets Inc's arthritis pain reliever containing diclofenac sodium under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arthritis Pain Reliever (Diclofenac sodium)

Snippet

SUPPL AP for ARTHRITIS PAIN RELIEVER (DICLOFENAC SODIUM)